Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Dr Reddys Laboratories (RDY) Revenue: 2020-2023

  • Dr Reddys Laboratories' Revenue rose 99.28% to -$1.1 billion in Q1 2023 from the same period last year, while for Mar 2023 it was -$152.1 billion, marking a year-over-year change of. This contributed to the annual value of $3.8 billion for FY2025, which is 13.76% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Revenue stood at -$1.1 billion for Q1 2023, which was up 99.28% from -$151.6 billion recorded in Q1 2022.
  • Dr Reddys Laboratories' Revenue's 5-year high stood at $366.0 million during Q4 2020, with a 5-year trough of -$151.6 billion in Q1 2022.
  • Moreover, its 2-year median value for Revenue was -$76.4 billion (2022), whereas its average is -$76.4 billion.
  • Data for Dr Reddys Laboratories' Revenue shows a peak YoY soared of 99.28% (in 2023) over the last 5 years.
  • Over the past 3 years, Dr Reddys Laboratories' Revenue (Quarterly) stood at $366.0 million in 2020, then reached -$151.6 billion in 2022, then spiked by 99.28% to -$1.1 billion in 2023.
  • Its Revenue stands at -$1.1 billion for Q1 2023, versus -$151.6 billion for Q1 2022 and $366.0 million for Q4 2020.